NCT01951885 2023-09-11Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD PreventionCase Comprehensive Cancer CenterPhase 3 Completed101 enrolled 28 charts
NCT03602898 2021-06-30Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationFred Hutchinson Cancer CenterPhase 2 Withdrawn
NCT00489203 2021-02-03Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed140 enrolled
NCT01529827 2019-09-24Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesRoswell Park Cancer InstitutePhase 2 Completed94 enrolled 11 charts
NCT01789255 2018-07-24Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesNational Cancer Institute (NCI)Phase 2 Completed12 enrolled 11 charts